Aanwerving proef = ; Lopend onderzoek = ; Terminated trial = ; Gefinancierd door een IRDiRC-lid = ; Studie waarbij in minstens twee lidstaten ERN-leden betrokken zijn =

Nationale klinische studie(s)

IERLAND

County Dublin
DUBLIN

LAL-CL03: An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 in Children with Growth Failure Due to Lysosomal Acid Lipase Deficiency (Phase II/III) - IE

Children's Health Ireland @ Temple Street

National Centre for Inherited Metabolic Disorders

Meer details